160 related articles for article (PubMed ID: 31215275)
1. The association between HLA and non-Hodgkin lymphoma subtypes, among a transplant-indicated population.
Zhong C; Gragert L; Maiers M; Hill BT; Garcia-Gomez J; Gendzekhadze K; Senitzer D; Song J; Weisenburger D; Goldstein L; Wang SS
Leuk Lymphoma; 2019 Dec; 60(12):2899-2908. PubMed ID: 31215275
[TBL] [Abstract][Full Text] [Related]
2. Variation in effects of non-Hodgkin lymphoma risk factors according to the human leukocyte antigen (HLA)-DRB1*01:01 allele and ancestral haplotype 8.1.
Wang SS; Lu Y; Rothman N; Abdou AM; Cerhan JR; De Roos A; Davis S; Severson RK; Cozen W; Chanock SJ; Bernstein L; Morton LM; Hartge P
PLoS One; 2011; 6(11):e26949. PubMed ID: 22096508
[TBL] [Abstract][Full Text] [Related]
3. Association of HLA alleles with non-Hodgkin's lymphoma in Korean population.
Choi HB; Roh SY; Choi EJ; Yoon HY; Kim SY; Hong YS; Kim DW; Kim TG
Int J Hematol; 2008 Mar; 87(2):203-209. PubMed ID: 18301962
[TBL] [Abstract][Full Text] [Related]
4. Impact of HLA Alleles on Outcomes of Allogeneic Transplantation for B Cell Non-Hodgkin Lymphomas: A Center for International Blood and Marrow Transplant Research Analysis.
William BM; Wang T; Haagenson MD; Fleischhauer K; Verneris M; Hsu KC; de Lima MJ; Fernandez-Viña M; Spellman SR; Lee SJ; Hill BT
Biol Blood Marrow Transplant; 2018 Apr; 24(4):827-831. PubMed ID: 29155319
[TBL] [Abstract][Full Text] [Related]
5. Association of KIR Genes Polymorphism and its HLA Ligands in Diffuse Large B-cell Lymphoma.
Daniela Maira C; Amanda Vansan M; Fernando G; Silvia M; Sofia L; Márcia D; Francisco José Penteado A; Jeane Eliete Laguila V; Cármino Antonio S
Clin Lymphoma Myeloma Leuk; 2023 Jun; 23(6):438-445. PubMed ID: 37105848
[TBL] [Abstract][Full Text] [Related]
6. HLA Class I and II Diversity Contributes to the Etiologic Heterogeneity of Non-Hodgkin Lymphoma Subtypes.
Wang SS; Carrington M; Berndt SI; Slager SL; Bracci PM; Voutsinas J; Cerhan JR; Smedby KE; Hjalgrim H; Vijai J; Morton LM; Vermeulen R; Paltiel O; Vajdic CM; Linet MS; Nieters A; de Sanjose S; Cozen W; Brown EE; Turner J; Spinelli JJ; Zheng T; Birmann BM; Flowers CR; Becker N; Holly EA; Kane E; Weisenburger D; Maynadie M; Cocco P; Albanes D; Weinstein SJ; Teras LR; Diver WR; Lax SJ; Travis RC; Kaaks R; Riboli E; Benavente Y; Brennan P; McKay J; Delfau-Larue MH; Link BK; Magnani C; Ennas MG; Latte G; Feldman AL; Doo NW; Giles GG; Southey MC; Milne RL; Offit K; Musinsky J; Arslan AA; Purdue MP; Adami HO; Melbye M; Glimelius B; Conde L; Camp NJ; Glenn M; Curtin K; Clavel J; Monnereau A; Cox DG; Ghesquières H; Salles G; Bofetta P; Foretova L; Staines A; Davis S; Severson RK; Lan Q; Brooks-Wilson A; Smith MT; Roman E; Kricker A; Zhang Y; Kraft P; Chanock SJ; Rothman N; Hartge P; Skibola CF
Cancer Res; 2018 Jul; 78(14):4086-4096. PubMed ID: 29735552
[TBL] [Abstract][Full Text] [Related]
7. Human leukocyte antigen class I and II alleles in non-Hodgkin lymphoma etiology.
Wang SS; Abdou AM; Morton LM; Thomas R; Cerhan JR; Gao X; Cozen W; Rothman N; Davis S; Severson RK; Bernstein L; Hartge P; Carrington M
Blood; 2010 Jun; 115(23):4820-3. PubMed ID: 20385791
[TBL] [Abstract][Full Text] [Related]
8. A single center study of protective and susceptible HLA alleles and haplotypes with end-stage renal disease in China.
Pan Q; Ma X; Chen H; Fan S; Wang X; You Y; Wang Z; Sun L; Zhao X; Shen J; Tan R; Gong G; Gu M
Hum Immunol; 2019 Nov; 80(11):943-947. PubMed ID: 31521393
[TBL] [Abstract][Full Text] [Related]
9. Relationship between IL-10 gene polymorphisms and the risk of non-Hodgkin lymphoma: A meta-analysis.
Li G; Li D
Hum Immunol; 2016 May; 77(5):418-25. PubMed ID: 27006334
[TBL] [Abstract][Full Text] [Related]
10. The associations of HLA-A, -B, DRB1 alleles and haplotypes in Turkish lymphoma patients.
Uçar F; Sönmez M; Ermantaş N; Özbaş HM; Cansız A; Balcı M; Yılmazz M
Gene; 2016 Jul; 586(2):263-7. PubMed ID: 27063556
[TBL] [Abstract][Full Text] [Related]
11. HLA Polymorphism in Algerian Children With Lymphomas.
Galleze A; Raache R; Amroun H; Cherif N; Fadli M; Meçabih F; Mecheti B; Belhani M; Bensenouci A; Abbadi MC; Attal N
J Pediatr Hematol Oncol; 2015 Nov; 37(8):e458-61. PubMed ID: 26334430
[TBL] [Abstract][Full Text] [Related]
12. The role of HLA variation in lymphoma aetiology and survival.
Zhong C; Cozen W; Bolanos R; Song J; Wang SS
J Intern Med; 2019 Aug; 286(2):154-180. PubMed ID: 31155783
[TBL] [Abstract][Full Text] [Related]
13. The major histocompatibility complex conserved extended haplotype 8.1 in AIDS-related non-Hodgkin lymphoma.
Aissani B; Ogwaro KM; Shrestha S; Tang J; Breen EC; Wong HL; Jacobson LP; Rabkin CS; Ambinder RF; Martinez-Maza O; Kaslow RA
J Acquir Immune Defic Syndr; 2009 Oct; 52(2):170-9. PubMed ID: 19654554
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms in pattern-recognition genes in the innate immunity system and risk of non-Hodgkin lymphoma.
Hu W; Bassig BA; Xu J; Zheng T; Zhang Y; Berndt SI; Holford TR; Hosgood HD; Leaderer B; Yeager M; Menashe I; Boyle P; Zou K; Zhu Y; Chanock S; Lan Q; Rothman N
Environ Mol Mutagen; 2013 Jan; 54(1):72-7. PubMed ID: 23055202
[TBL] [Abstract][Full Text] [Related]
15. HLA-G Gene Polymorphism in Egyptian Patients with Non-Hodgkin Lymphoma and its Clinical Outcome.
Tawfeek GA; Alhassanin S
Immunol Invest; 2018 Apr; 47(3):315-325. PubMed ID: 29388862
[TBL] [Abstract][Full Text] [Related]
16. Haplotype-specific pattern of association of human major histocompatibility complex with non-Hodgkin's lymphoma outcome.
Nowak J; Kalinka-Warzocha E; Juszczyński P; Mika-Witkowska R; Zajko M; Graczyk-Pol E; Coiffier B; Salles G; Warzocha K
Tissue Antigens; 2008 Jan; 71(1):16-26. PubMed ID: 17971052
[TBL] [Abstract][Full Text] [Related]
17. Genetic overlap between autoimmune diseases and non-Hodgkin lymphoma subtypes.
Din L; Sheikh M; Kosaraju N; Smedby KE; Bernatsky S; Berndt SI; Skibola CF; Nieters A; Wang S; McKay JD; Cocco P; Maynadié M; Foretová L; Staines A; Mack TM; de Sanjosé S; Vyse TJ; Padyukov L; Monnereau A; Arslan AA; Moore A; Brooks-Wilson AR; Novak AJ; Glimelius B; Birmann BM; Link BK; Stewart C; Vajdic CM; Haioun C; Magnani C; Conti DV; Cox DG; Casabonne D; Albanes D; Kane E; Roman E; Muzi G; Salles G; Giles GG; Adami HO; Ghesquières H; De Vivo I; Clavel J; Cerhan JR; Spinelli JJ; Hofmann J; Vijai J; Curtin K; Costenbader KH; Onel K; Offit K; Teras LR; Morton L; Conde L; Miligi L; Melbye M; Ennas MG; Liebow M; Purdue MP; Glenn M; Southey MC; Din M; Rothman N; Camp NJ; Wong Doo N; Becker N; Pradhan N; Bracci PM; Boffetta P; Vineis P; Brennan P; Kraft P; Lan Q; Severson RK; Vermeulen RCH; Milne RL; Kaaks R; Travis RC; Weinstein SJ; Chanock SJ; Ansell SM; Slager SL; Zheng T; Zhang Y; Benavente Y; Taub Z; Madireddy L; Gourraud PA; Oksenberg JR; Cozen W; Hjalgrim H; Khankhanian P
Genet Epidemiol; 2019 Oct; 43(7):844-863. PubMed ID: 31407831
[TBL] [Abstract][Full Text] [Related]
18. HLA class II polymorphism in Egyptian children with lymphomas.
Al-Tonbary Y; Abdel-Razek N; Zaghloul H; Metwaly S; El-Deek B; El-Shawaf R
Hematology; 2004 Apr; 9(2):139-45. PubMed ID: 15203870
[TBL] [Abstract][Full Text] [Related]
19. Pleiotropy of cancer susceptibility variants on the risk of non-Hodgkin lymphoma: the PAGE consortium.
Lim U; Kocarnik JM; Bush WS; Matise TC; Caberto C; Park SL; Carlson CS; Deelman E; Duggan D; Fesinmeyer M; Haiman CA; Henderson BE; Hindorff LA; Kolonel LN; Peters U; Stram DO; Tiirikainen M; Wilkens LR; Wu C; Kooperberg C; Le Marchand L
PLoS One; 2014; 9(3):e89791. PubMed ID: 24598796
[TBL] [Abstract][Full Text] [Related]
20. Tracking the Genetic Susceptibility Background of B-Cell Non-Hodgkin's Lymphomas from Genome-Wide Association Studies.
Hernández-Verdin I; Labreche K; Benazra M; Mokhtari K; Hoang-Xuan K; Alentorn A
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]